Countries respond to link made between AstraZeneca vaccine and blood clots

A doctor with an AstraZeneca vaccine container at a vaccination center in Bucharest, Romania. Source: AAP

The European Medicines Agency remains adamant the benefits of the AstraZeneca COVID-19 vaccine outweigh the risks. Countries across Europe are now deciding on their own what to do next.

Follow and Subscribe

Download (11.19MB)

Download the SBS Audio appAvailable on iOS and Android

Published 8 April 2021 10:37am

By Sofija Petrovic

Source: SBS

Share this with family and friends

The European Medicines Agency remains adamant the benefits of the AstraZeneca COVID-19 vaccine outweigh the risks. Countries across Europe are now deciding on their own what to do next.

For health and support measures currently in place in response to the COVID-19 pandemic in your language, visit sbs.com.au/coronavirus

Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

Watch FIFA World Cup 2026™

Countries respond to link made between AstraZeneca vaccine and blood clots

Follow and Subscribe

The European Medicines Agency remains adamant the benefits of the AstraZeneca COVID-19 vaccine outweigh the risks. Countries across Europe are now deciding on their own what to do next.

Follow and Subscribe

The European Medicines Agency remains adamant the benefits of the AstraZeneca COVID-19 vaccine outweigh the risks. Countries across Europe are now deciding on their own what to do next.

Follow SBS News

Download our apps

Listen to our podcasts

Watch on SBS